Alumni raised $1.45B in 2022 - Download Free Report Now

TriVascular Technologies (NASDAQ:TRIV)

Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of TriVascular Technologies (NASDAQ:TRIV) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About TriVascular Technologies (NASDAQ:TRIV)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With